These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33533011)

  • 1. Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation.
    Bamia A; Sinane M; Naït-Saïdi R; Dhiab J; Keruzoré M; Nguyen PH; Bertho A; Soubigou F; Halliez S; Blondel M; Trollet C; Simonelig M; Friocourt G; Béringue V; Bihel F; Voisset C
    Neurotherapeutics; 2021 Apr; 18(2):1137-1150. PubMed ID: 33533011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology and Genetics of PrP Prion Strains.
    Ghaemmaghami S
    Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 27920025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation Significantly Inhibits the Aggregation of Human Prion Protein and Decreases Its Cytotoxicity.
    Yi CW; Wang LQ; Huang JJ; Pan K; Chen J; Liang Y
    Sci Rep; 2018 Aug; 8(1):12603. PubMed ID: 30135544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice.
    Ishibashi D; Ishikawa T; Mizuta S; Tange H; Nakagaki T; Hamada T; Nishida N
    Neurotherapeutics; 2020 Oct; 17(4):1836-1849. PubMed ID: 32767031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The double life of the ribosome: When its protein folding activity supports prion propagation.
    Voisset C; Blondel M; Jones GW; Friocourt G; Stahl G; Chédin S; Béringue V; Gillet R
    Prion; 2017 Mar; 11(2):89-97. PubMed ID: 28362551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein folding activity of the ribosome (PFAR) -- a target for antiprion compounds.
    Banerjee D; Sanyal S
    Viruses; 2014 Oct; 6(10):3907-24. PubMed ID: 25341659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
    Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
    Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cofactors influence the biological properties of infectious recombinant prions.
    Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
    Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Octapeptide Repeats on Prion Folding and Misfolding.
    Yu KH; Huang MY; Lee YR; Lin YK; Chen HR; Lee CI
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment.
    Shan Z; Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    Prion; 2016 Jul; 10(4):305-18. PubMed ID: 27565564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
    Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
    Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.
    Barbezier N; Chartier A; Bidet Y; Buttstedt A; Voisset C; Galons H; Blondel M; Schwarz E; Simonelig M
    EMBO Mol Med; 2011 Jan; 3(1):35-49. PubMed ID: 21204267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The suppression of prion propagation using poly-L-lysine by targeting plasminogen that stimulates prion protein conversion.
    Ryou C; Titlow WB; Mays CE; Bae Y; Kim S
    Biomaterials; 2011 Apr; 32(11):3141-9. PubMed ID: 21288569
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecules with Anti-Prion Activity.
    Mustazza C; Sbriccoli M; Minosi P; Raggi C
    Curr Med Chem; 2020; 27(33):5446-5479. PubMed ID: 31560283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedure for identification and characterization of drugs efficient against mammalian prion: from a yeast-based antiprion drug screening assay to in vivo mouse models.
    Voisset C; Saupe SJ; Galons H; Blondel M
    Infect Disord Drug Targets; 2009 Feb; 9(1):31-9. PubMed ID: 19200013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovine recombinant PrP as an inhibitor of ruminant prion propagation in vitro.
    Workman RG; Maddison BC; Gough KC
    Prion; 2017 Jul; 11(4):265-276. PubMed ID: 28665745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanisms of humic substances self-assembly with biological molecules: The case study of the prion protein.
    Giachin G; Nepravishta R; Mandaliti W; Melino S; Margon A; Scaini D; Mazzei P; Piccolo A; Legname G; Paci M; Leita L
    PLoS One; 2017; 12(11):e0188308. PubMed ID: 29161325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein post-translational modifications modulate heparan sulfate binding and limit aggregate size in prion disease.
    Callender JA; Sevillano AM; Soldau K; Kurt TD; Schumann T; Pizzo DP; Altmeppen H; Glatzel M; Esko JD; Sigurdson CJ
    Neurobiol Dis; 2020 Aug; 142():104955. PubMed ID: 32454127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel fluorescent probes preventing PrP
    Zaccagnini L; Brogi S; Brindisi M; Gemma S; Chemi G; Legname G; Campiani G; Butini S
    Eur J Med Chem; 2017 Feb; 127():859-873. PubMed ID: 27842893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.